Back

Spatial regulation of the glycocalyx component Podocalyxin is a switch for pro-metastatic function

Roman-Fernandez, A.; Mansour, M.; Kugeratski, F. G.; Anand, J.; Sandilands, E.; Galbraith, L.; Rakovic, K.; Freckmann, E. C.; Cumming, E. M.; Park, J.; Nikolatou, K.; Lilla, S.; Shaw, R.; Strachan, D.; Mason, S.; Patel, R.; McGarry, L.; Katoch, A.; Campbell, K.; Nixon, C.; Miller, C. J.; Leung, H. Y.; Le Quesne, J.; Norman, J. C.; Zanivan, S. R.; Blyth, K.; Bryant, D. M.

2022-11-04 cell biology
10.1101/2022.11.04.515043 bioRxiv
Show abstract

The glycocalyx component and sialomucin Podocalyxin (PODXL) is required for normal tissue development by promoting apical membranes to form between cells, triggering lumen formation. Elevated PODXL expression is also associated with metastasis and poor clinical outcome in multiple tumour types. How PODXL presents this duality in effect remains unknown. We identify an unexpected function of PODXL as a decoy receptor for Galectin-3 (GAL3), whereby the PODXL-GAL3 interaction releases GAL3 repression of integrin-based invasion. Differential cortical targeting of PODXL, regulated by ubiquitination, is the molecular mechanism controlling alternate fates. Both PODXL high versus low surface levels occur in parallel subpopulations within cancer cells. Orthotopic intraprostatic xenograft of PODXL-manipulated cells or those with different surface levels of PODXL define that this axis controls metastasis in vivo. Clinically, interplay between PODXL-GAL3 stratifies prostate cancer patients with poor outcome. Our studies define the molecular mechanisms and context in which PODXL promotes invasion and metastasis.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.